4U6-28279-42655 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-29
Dose 1 — Pfizer-BioNTech
2021-01-17
Registered in v-safe
2021-01-17
Dose 2 — Pfizer-BioNTech
2021-01-17
Survey response — day 0, dose 2
MedDRA: Headache, Migraine — Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness

Free text: After the first injection (didn't have reporting information) had a migraine daily (lasting approx 1-2 hours) and constant headache for the first week post injection and then had daily headaches (lasting throughout day) without relief from nsaids for the second week following the injection.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-18
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-19
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Headache

Adult check-in
2021-07-18
Survey response — 6 months, dose 2
MedDRA: Fatigue, Migraine, Muscular weakness — Feeling: Fair · Be unable to do your normal daily activities

Free text: Migraines have become regular, severe fatigue and muscle weakness.

MedDRA releases: 2024-11 · check-in free text available
2022-01-17
Survey response — 12 months, dose 2
MedDRA: Abnormal uterine bleeding, Infection, SARS-CoV-2 test positive — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Tested COVID positive, have been treated for 2 different infections, and have a new uterine bleeding disorder.

MedDRA releases: 2024-11 · check-in free text available
2022-01-17
Report sent to call center — 12 months, dose 2
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-01-18
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-29	Pfizer-BioNTech
2	2021-01-17	Pfizer-BioNTech

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 2 — day 0, dose 2

2021-01-17

Systemic reaction (other): After the first injection (didn't have reporting information) had a migraine daily (lasting approx 1-2 hours) and constant headache for the first week post injection and then had daily headaches (lasting throughout day) without relief from nsaids for the second week following the injection.

Release 9 — 6 months, dose 2

2021-07-18

Symptoms: Migraines have become regular, severe fatigue and muscle weakness.

Release 10 — 12 months, dose 2

2022-01-17

Symptoms: Tested COVID positive, have been treated for 2 different infections, and have a new uterine bleeding disorder.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Abnormal uterine bleeding	·	·	✓
SD	Fatigue	·	·	✓
SD	Infection	·	·	✓
SD	Migraine	·	·	✓
SD	Muscular weakness	·	·	✓
SD	SARS-CoV-2 test positive	·	·	✓
SRO	Headache	✓	✓	✓
SRO	Migraine	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release